New Aspects of the Epigenetics of Pancreatic Carcinogenesis.


Journal

Epigenomes
ISSN: 2075-4655
Titre abrégé: Epigenomes
Pays: Switzerland
ID NLM: 101736595

Informations de publication

Date de publication:
Sep 2020
Historique:
entrez: 5 10 2020
pubmed: 6 10 2020
medline: 6 10 2020
Statut: ppublish

Résumé

Pancreatic cancer remains among the deadliest forms of cancer with a 5 year survival rate less than 10%. With increasing numbers being observed, there is an urgent need to elucidate the pathogenesis of pancreatic cancer. While both contribute to disease progression, neither genetic nor environmental factors completely explain susceptibility or pathogenesis. Defining the links between genetic and environmental events represents an opportunity to understand the pathogenesis of pancreatic cancer. Epigenetics, the study of mitotically heritable changes in genome function without a change in nucleotide sequence, is an emerging field of research in pancreatic cancer. The main epigenetic mechanisms include DNA methylation, histone modifications and RNA interference, all of which are altered by changes to the environment. Epigenetic mechanisms are being investigated to clarify the underlying pathogenesis of pancreatic cancer including an increasing number of studies examining the role as possible diagnostic and prognostic biomarkers. These mechanisms also provide targets for promising new therapeutic approaches for this devastating malignancy.

Identifiants

pubmed: 33014438
doi: 10.3390/epigenomes4030018
pmc: PMC7528595
mid: NIHMS1630427
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R01 CA136526
Pays : United States

Déclaration de conflit d'intérêts

Conflicts of Interest: The authors declare no conflict of interest.

Références

Cell. 2007 Feb 23;128(4):693-705
pubmed: 17320507
Nutrition. 2004 Jan;20(1):56-62
pubmed: 14698015
Nature. 1959 Jun 13;183(4676):1654-5
pubmed: 13666847
Int J Epidemiol. 2012 Feb;41(1):10-3
pubmed: 22186258
Nature. 2001 Feb 15;409(6822):860-921
pubmed: 11237011
Nature. 2007 May 24;447(7143):396-8
pubmed: 17522671
Nat Med. 2010 Jan;16(1):90-7
pubmed: 19966812
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10202-10207
pubmed: 28874546
J Autoimmun. 2010 May;34(3):J207-19
pubmed: 20053532
Nature. 2001 Feb 15;409(6822):934-41
pubmed: 11237014
Oncol Rep. 2009 Jun;21(6):1439-47
pubmed: 19424621
Science. 2001 Aug 10;293(5532):1089-93
pubmed: 11498579
Nat Rev Genet. 2004 Jul;5(7):522-31
pubmed: 15211354
Nutr Rev. 2007 Feb;65(2):88-94
pubmed: 17345961
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Clin Cancer Res. 2000 Aug;6(8):2969-72
pubmed: 10955772
Nat Commun. 2015 Jul 07;6:7686
pubmed: 26154128

Auteurs

Murat Toruner (M)

Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Department of Gastroenterology, Ankara University School of Medicine, School of Medicine, 06100 Ankara, Turkey.

Martin E Fernandez-Zapico (ME)

Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Christopher L Pin (CL)

Departments of Paediatrics, Oncology, and Physiology and Pharmacology, University of Western Ontario, Children's Health Research Institute, London, ON N6C 2V5, Canada.

Classifications MeSH